Polycystic ovary syndrome.
D001971:Bromocriptine / Q000627:therapeutic use; D002996:Clomiphene / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004338:Drug Combinations; D004997:Ethinyl Estradiol / Q000627:therapeutic use; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D006801:Humans; D007664:Ketosteroids / Q000378:metabolism; D007986:Luteinizing Hormone / Q000378:metabolism; D008525:Medroxyprogesterone / Q000627:therapeutic use; D010053:Ovary / Q000473:pathology; D011085:Polycystic Ovary Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000601:surgery; D011241:Prednisone / Q000627:therapeutic use; D013739:Testosterone / Q000032:analysis; D013997:Time Factors
D004338:Drug Combinations; D007664:Ketosteroids; D002996:Clomiphene; D001971:Bromocriptine; D013739:Testosterone; D004997:Ethinyl Estradiol; D003907:Dexamethasone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D008525:Medroxyprogesterone; D011241:Prednisone